Clinical trial
Multicenter Clinical Trial for Adult Ph-negative ALL. Evaluation of the Impact of the Prolonged L-asparaginase Therapy During Continuous Treatment With Modification of Cytostatic Drugs Doses Depending on Myelosuppression Severity.
NCT01193933 is registered in ClinicalTrials.gov with National Research Center for Hematology, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Clinical Trial for Adult Ph-negative ALL. Evaluation of the Impact of the Prolonged L-asparaginase Therapy During Continuous Treatment With Modification of Cytostatic Drugs Doses Depending on Myelosuppression Severity.
- Lead sponsor
- National Research Center for Hematology, Russia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2008
- Completion date
- December 31, 2021
- Enrollment
- 321 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ph-negative adult acute lymphoblastic leukemia